Početna stranicaLAURUSLABS • NSE
add
Laurus Labs Ltd
Preth. zaklj. cijena
603,85 ₹
Dnevni raspon
605,00 ₹ - 624,60 ₹
Godišnji raspon
385,45 ₹ - 660,90 ₹
Tržišna kapitalizacija
334,07 mlr. INR
Prosječna količina
2,26 mil.
P/E omjer
93,09
Prinos dividende
0,19 %
Glavno tržište vrijednosnica
NSE
Vijesti s tržišta
Financijski podaci
Račun dobiti i gubitka
Prihod
Neto dohodak
| (INR) | ožu 2025.info | Godišnja promjena |
|---|---|---|
Prihod | 17,79 mlr. | 23,56 % |
Operativni troškovi | 6,27 mlr. | 31,56 % |
Neto dohodak | 2,34 mlr. | 209,05 % |
Neto profitabilnost | 13,14 | 150,29 % |
Zarada po dionici | 4,33 | 209,29 % |
EBITDA | 4,76 mlr. | 111,32 % |
Efektivna porezna stopa | 25,21 % | — |
Bilanca stanja
Ukupna imovina
Ukupne obveze
| (INR) | ožu 2025.info | Godišnja promjena |
|---|---|---|
Gotovinska i kratkoročna ulaganja | 506,40 mil. | −64,25 % |
Ukupna imovina | 85,87 mlr. | 2,38 % |
Ukupne obveze | 40,23 mlr. | −5,82 % |
Ukupni kapital | 45,64 mlr. | — |
Dionice u optjecaju | 538,41 mil. | — |
Cijena prema knjigovodstvenoj vrijednosti | 7,12 | — |
Povrat imovine | — | — |
Povrat kapitala | 13,29 % | — |
Tok novca
Neto promjena novca
| (INR) | ožu 2025.info | Godišnja promjena |
|---|---|---|
Neto dohodak | 2,34 mlr. | 209,05 % |
Gotovina od poslovanja | — | — |
Gotovina iz ulaganja | — | — |
Gotovina iz financiranja | — | — |
Neto promjena novca | — | — |
Slobodan tok novca | — | — |
Više
Laurus Labs is an Indian multinational pharmaceutical and biotechnology company headquartered in Hyderabad. Its focus areas include active pharmaceutical ingredients, generic formulations, custom synthesis, biotechnology, veterinary APIs and agrochemicals. The company was founded in 2005 by Satyanarayana Chava.
Laurus Labs has its eight manufacturing plants located at Visakhapatnam, Hyderabad and Bangalore. The manufacturing units have received one or more approvals from USFDA, WHO, NIP Hungary, KFDA, MHRA, TGA, and PMDA. The company operates through its subsidiaries in Europe and United States and also offers its services in contract research, clinical research and analytical research through its R&D centers. The R&D centres are based in Hyderabad, Visakhapatnam and United States. Wikipedia
Glavni izvršni direktor
Osnovano
2005
Web-lokacija
Zaposlenici
6.007
